Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND3 pseudogene 1 (MTND3P1) refers to a non-functional, non-protein-coding segment of nuclear or mitochondrial DNA that resembles the protein-coding gene MT-ND3 but does not produce a functional protein. While the functional MT-ND3 gene encodes a core subunit of mitochondrial respiratory chain complex I critical for electron transport and ATP production[1][2][3], the pseudogene MTND3P1 does not encode an active protein, is not part of the electron transport chain, and has no confirmed biological or disease role. MTND3P1 is *not* a drug target, receptor, enzyme, or transporter[1][3]. Its presence in gene catalogs is for genomic reference and should not be mistaken for the protein-coding MT-ND3 subunit, which is implicated in mitochondrial disorders such as Leigh syndrome and Leber hereditary optic neuropathy[1][2][3]. Summary of key distinctions: - MTND3P1 is a **pseudogene**, so it is not a functional, therapeutic, or druggable target and should not be reported as one. - The functional target associated with mitochondrial complex I and disease is **MT-ND3 (NADH dehydrogenase 3)**, not its pseudogene. If a therapeutic target is required, use the canonical name "NADH dehydrogenase [ubiquinone] 3, mitochondrial" (MT-ND3), not the pseudogene. MTND3P1 should not be used as a therapeutic target entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND3 pseudogene 1 (MTND3P1).